APLIF (MC $65 M) Covid 19 Phase 3 results NEXT MONTH = 10 Bagger Potential

Discussion in 'Stock picks and trading strategies' started by DollarChamp, Feb 12, 2021.

  1. DollarChamp

    DollarChamp Member

    Very low valuation of $65 million ,well financed with $20 million and BIG milestones is aorund the corner with the Phase 3 readout of the Covid 19 program and potential approval of the drug in Canada both expected during THIS Quarter . They expect to submit 2 NDA´s during the year including the covid 19 treatment . This under radar stock has potential to run to $10 and even higher .STRONG BUY

    Market Cap $65 million
    Cash $20 million
    Price $1.03


    Adding to the COVID-19 treatment toolbox

    APLIF: Phase 3 PRESECO Trial Readout in Late March 2021…



Share This Page